Methylenebutyrylphenoxyacetic acid en es it fr

Methylenebutyrylphenoxyacetic acid Brand names, Methylenebutyrylphenoxyacetic acid Analogs

Methylenebutyrylphenoxyacetic acid Brand Names Mixture

  • No information avaliable

Methylenebutyrylphenoxyacetic acid Chemical_Formula

C13H12Cl2O4

Methylenebutyrylphenoxyacetic acid RX_link

http://www.rxlist.com/cgi/generic3/edecrin.htm

Methylenebutyrylphenoxyacetic acid fda sheet

Methylenebutyrylphenoxyacetic_acid FDA

Methylenebutyrylphenoxyacetic acid msds (material safety sheet)

Methylenebutyrylphenoxyacetic_acid MSDS

Methylenebutyrylphenoxyacetic acid Synthesis Reference

No information avaliable

Methylenebutyrylphenoxyacetic acid Molecular Weight

303.137 g/mol

Methylenebutyrylphenoxyacetic acid Melting Point

122.5 oC

Methylenebutyrylphenoxyacetic acid H2O Solubility

No information avaliable

Methylenebutyrylphenoxyacetic acid State

Solid

Methylenebutyrylphenoxyacetic acid LogP

3.414

Methylenebutyrylphenoxyacetic acid Dosage Forms

Tablet (25, 50 mg); Powder for solution

Methylenebutyrylphenoxyacetic acid Indication

For the treatment of high blood pressure and edema caused by diseases like congestive heart failure, liver failure, and kidney failure.

Methylenebutyrylphenoxyacetic acid Pharmacology

Ethacrynic acid is a monosulfonamyl loop or high ceiling diuretic. Ethacrynic acid acts on the ascending limb of the loop of Henle and on the proximal and distal tubules. Urinary output is usually dose dependent and related to the magnitude of fluid accumulation. Water and electrolyte excretion may be increased several times over that observed with thiazide diuretics, since ethacrynic acid inhibits reabsorption of a much greater proportion of filtered sodium than most other diuretic agents. Therefore, ethacrynic acid is effective in many patients who have significant degrees of renal insufficiency. Ethacrynic acid has little or no effect on glomerular filtration or on renal blood flow, except following pronounced reductions in plasma volume when associated with rapid diuresis.

Methylenebutyrylphenoxyacetic acid Absorption

Onset of action is rapid, usually within 30 minutes after an oral dose of ethacrynic acid or within 5 minutes after an intravenous injection of ethacrynic acid.

Methylenebutyrylphenoxyacetic acid side effects and Toxicity

Overdosage may lead to excessive diuresis with electrolyte depletion.

Methylenebutyrylphenoxyacetic acid Patient Information

No information avaliable

Methylenebutyrylphenoxyacetic acid Organisms Affected

Humans and other mammals